Skip to main content

Information:

Online Consultation

In order to comply with the required GP contract changes on 01.10.25, the online consultation platform Patchs will be open to our patients during the practices core working hours of 08.00 – 18.30.  As a measure of patient safety, please do not complete a Patchs if you consider your problem or symptoms to be urgent in order to avoid any unnecessary delays in your treatment.  Please contact the practice directly in these circumstances to obtain the appropriate advice.

Tirzepatide (Mounjaro®) FAQs

What is changing in the management of obesity?

People in England over the age of 18 living with obesity and weight-related health
issues, will be able to access the weight loss drug Tirzepatide (Mounjaro®).

Tirzepatide is currently prescribed for the treatment of type 2 diabetes mellitus but
will now also be available for weight loss purposes

For more information, please the see the Tirzepatide (Mounjaro®) FAQs (PDF).